Goldman Sachs CEO David Solomon was awarded an $80 million stock bonus to stay at the helm for another five years, a stark turnaround for a leader whose survival was questioned after the firm's ...
Goldman Sachs reaffirmed their positive stance on Madrigal Pharmaceuticals (NASDAQ:MDGL), maintaining a Buy rating and a price target of $530.00. Currently trading at $274.41, the stock shows ...